|Other names||Lilly 113935; LY-113935|
|Drug class||Nonsteroidal antiandrogen|
|Chemical and physical data|
|Molar mass||394.460 g/mol g·mol−1|
|3D model (JSmol)|
Pentomone (INN, USAN) (developmental code name Lilly 113935 or LY-113935) is a nonsteroidal antiandrogen (NSAA) described as a "prostate growth inhibitor" which was never marketed. It was synthesized and assayed in 1978.
|This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it.|